I don’t know why you spend so much time here fleshing out your theories on how to run a biotech company that is expanding it’s product take up and world reach at a rate that is envied by other companies and applauded by many highly credible analysts.
Surely your time would be better spent by emailing DW direct, informing him of where he is going wrong and then offer your services to him as a business consultant, to stop him making anymore catastrophic mistakes with the companies capital resources and direction.
PNV - Banter and General Comments, page-10587
-
- There are more pages in this discussion • 2,022 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.39 |
Change
0.000(0.00%) |
Mkt cap ! $1.650B | |||
| Open | High | Low | Value | Volume |
| $2.40 | $2.41 | $2.37 | $1.760M | 736.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23241 | $2.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.39 | 381 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |